Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000983

Drug Information
NameSibenadet
CompanyAstraZeneca
IndicationChronic obstructive pulmonary disease
[ICD9: 490-492, 494-496   ICD10: J40-J44, J47]
Discontinued in Phase III    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C26H14N8O7S/c1-9-17-24-30-14(6-39-24)21-28-12(4-37-21)19-27-11
(3-35-19)20-29-13(5-36-20)22-31-15(7-38-22)26-32-16(8-42-26)23-33
-18(10(2)40-23)25(34-17)41-9/h3-7,16H,8H2,1-2H3
InChIKeyYVSQVYZBDXIXCC-UHFFFAOYSA-N
Canonical SMILESCC1=C2C3=NC(=C(O3)C)C4=NC(=CO4)C5=NC(=CO5)C6=NC(=CO6)C7=NC(=CO7)C8=NC(=
CO8)C9=NC(CS9)C(=N2)O1    
CAS NumberCAS 154189-24-9
FormulaC22H29ClN2O5S2
FormulaC22H29ClN2O5S3
FormulaC22H29ClN2O5S4
FormulaC22H29ClN2O5S5
PubChem Compound IDCID 443590.
TargetBeta-2 adrenergic receptorAgonist[2]
Beta-2 adrenergic receptorMultitarget[2]
D(2) dopamine receptorAgonist[2]
D(2) dopamine receptorMultitarget[2]
Ref 1Anti-obesity drugs and neural circuits of feeding. Trends Pharmacol Sci. 2008 Apr;29(4):208-17. Epub 2008 Mar 18. To Reference
Ref 2Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543